OVIDのPER（株価収益率）は？

Ovid Therapeutics Inc（OVID）は現在PER 51.18倍で取引されています。

OVIDのROE（自己資本利益率）は？

Ovid Therapeutics IncのROEは-12.19%です。

OVIDの配当利回りは？

Ovid Therapeutics Incの配当利回りは0.00%です。

OVIDの品質スコア（Quality Score）は？

当社のAIはOVIDの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

OVIDは今が買い時ですか？

当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

OVIDはどのセクターに属しますか？

Ovid Therapeutics IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

OVID (NASDAQ) 株価分析 | Ovid Therapeutics Inc

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-07 | FS: 2026-03-31)

OVID AI Analysis Summary

Our AI summary for OVID: Ovid Therapeutics Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 51.18, ROE of -12.19%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

OVID

Ovid Therapeutics Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 93

USD 2.63

-0.02 (-0.75%) Day Change

Watchlist Portfolio Compare Chart

51.18

P/E

0.01

D/E

-12.2%

ROE

-10.7%

ROA

0.00%

Div Yield

-1.81

PEG

OVID THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.63 Price -0.02 (-0.75%) Day Change	NEWS SCORE: 93

OVID, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	93
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.63
PBV / Sector	2.49 / 5.54
Earning Per Share	-0.13

PE / Sector	51.18 / 21.47
PEG or PE/Growth / Sector	-1.81 / 1.07
Average 1M Daily Value	3.59 M GREAT
Average 1W Daily Value	3.97 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-339.33 / 94.92
NPM Average (%) / Sector	-4,404.47 / -2,098.06
NPM Change Average (%) / Sector	42.93 / 4,908.35 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-10.71 / 25.82
ROA Average (%) / Sector	-24.08 / -345.24
ROA Change Average (%) / Sector	-19.56 / 5,181.60
ROE (%) / Sector	-12.19 / 4.09
ROE Average (%) / Sector	-32.55 / 2.46
ROE Change Average (%) / Sector	-13.94 / 3,089.18
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.03
Dividend Average (%) / Sector	N/A / 17.00
Dividend Change Average (%) / Sector	N/A / -2.00

登録情報

Analyze Date	2026-08-08 08:04:34
Symbol	OVID
Name	OVID THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	186.64 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	494.60 / 9,564.45

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Hudson Commons, New York, NY, United States, 10001

Phone: 646 661 7661

Website: https://www.ovidrx.com

Sector: Healthcare >> Biotechnology

Description: Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.